Argos Therapeutics expands board
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Argos Therapeutics Inc. added Ralph Snyderman and Irackly Mtibelishvily to its board.
Snyderman is the director of the Duke Center for Research on Personalized Health Care while Mtibelishvily is Citigroup's managing director and chairman of corporate and investment banking in central and eastern Europe, the Middle East and Africa.
